Skip to main content
Year archive

Genome&Company — 2022 filings

All 38 regulatory filings released by Genome&Company (314130) in 2022, sourced directly from the official regulator.

38 Filings
2022 Period
2022 filings (38)
Filing Released Lang
주주명부폐쇄기간또는기준일설정
Regulatory Filings
2022-12-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-12-08 Korean
투자판단관련주요경영사항(마이크로바이옴 면역항암 치료제 GEN-001의 고형암 환자 대상 임상1/1b상 시험 조기 종료)
Legal Proceedings Report
2022-12-06 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-12-06 Korean
분기보고서 (2022.09)
Interim / Quarterly Report 9M 2022
2022-11-28 Korean
투자판단관련주요경영사항(마이크로바이옴 면역항암 치료제 GEN-001의 담도암 환자 대상 국내 제2상 임상시험계획 (IND) 승인)
Regulatory Filings
2022-11-08 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-11-08 Korean
투자판단관련주요경영사항(마이크로바이옴 면역항암 치료제 GEN-001의 담도암 환자 대상 국내 제2상 임상시험계획(IND) 신청)
Regulatory Filings
2022-09-26 Korean
증권발행결과(자율공시)(제3자배정 유상증자-전환우선주)
Share Issue/Capital Change
2022-09-19 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-09-19 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2022-09-15 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change
2022-09-02 Korean
반기보고서 (2022.06)
Interim / Quarterly Report H1 2022
2022-08-29 Korean
[기재정정]주요사항보고서(유상증자결정)
Capital/Financing Update
2022-08-26 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-08-22 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2022-08-18 Korean
주요사항보고서(유상증자결정)
Share Issue/Capital Change
2022-08-18 Korean
[기재정정]사업보고서 (2021.12)
Annual Report FY 2021
2022-07-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-06-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-06-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2022-06-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-06-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-06-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-06-23 Korean
분기보고서 (2022.03)
Interim / Quarterly Report Q1 2022
2022-05-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2022-05-30 Korean
기업설명회(IR)개최
Report Publication Announcement
2022-05-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2022-03-29 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2022-03-29 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2022-03-29 Korean
대표이사변경
Board/Management Information
2022-03-25 Korean
유상증자결정(종속회사의주요경영사항)
Capital/Financing Update
2022-03-23 Korean
감사보고서제출
Audit Report / Information FY 2021
2022-03-21 Korean
사업보고서 (2021.12)
Audit Report / Information FY 2021
2022-03-21 Korean
주주총회소집결의
AGM Information
2022-03-14 Korean
주주총회소집공고
AGM Information
2022-03-14 Korean
기타경영사항(자율공시)(담도암 2상 임상시험 협력 및 의약품 지원 계약 체결)
Regulatory Filings
2022-03-04 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2021
2022-02-14 Korean